Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
Moreover, pericytes and infiltrating peripheral immune cells also contribute to the neuroinflammatory cascade
There is no one-size-fits-all schedule, and it is essential for the treatment regimen to be carefully managed
2025 May 1;66(5):19
10.1002/advs.202004303 70 GuoQ.QiuP.PanK.LinJ
Waar BPC-157 aangrijpt op vasculaire stabilisatie, groeifactorreceptorexpressie en stikstofmonoxide-signalering, reguleert TB-500 de cytoskeletale organisatie die celmigratie en weefselremodellering aanstuurt
US$ 23.71
US$ 24.22
US$ 20.67
US$ 23.55